Inoviq Ltd (AU:IIQ) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Inoviq Ltd has announced a breakthrough in ovarian cancer testing, with its EXO-OC blood test achieving over 94% accuracy in independent patient validation. This promising development could revolutionize early-stage ovarian cancer detection, crucially improving patient outcomes and survival rates. The company plans to optimize the test for commercial use and further clinical validation.
For further insights into AU:IIQ stock, check out TipRanks’ Stock Analysis page.
